Thursday, July 19, 2012

Quick Sauerkraut

Back to the Homestead - Quick Sauerkraut




Directly translated, Sauerkraut means "sour cabbage." Sauerkraut is finely shredded cabbage that has been fermented by various lactic acid bacteria, including Leuconostoc, Lactobacillus, and Pediococcus. It has a long shelf-life and a distinctive sour flavor, both of which result from the lactic acid that forms when the bacteria ferment the sugars in the cabbage. It is not to be confused with coleslaw, which consists of fresh cabbage and may receive an acidic taste from vinegar (so says Wikipedia).

Vitamin C in Sauerkraut: 100 Grams has 15mg
Vitamin C in Cabbage: 100 Grams has 37mg
Vitamin C in an Orange: 100 Grams has 53mg

Sauerkraut wonderful all by itself. I especially enjoy sauerkraut mixed up in salads and even cooked into other recipes (though the benefits of the homemade sauerkraut is lost during cooking).

Here is my recipie:

3 Tablespoons of Sea Salt to 5 Pounds of Cabbage.

In the video, I had 3 pounds of cabbage that I prepared. When considering 3 pounds is 60% of 5 pounds, we used 60% of the salt needed for 5 pounds of cabbage.

1 Tablespoon = 3 Teaspoons
3 Tablespoons = 9 Teaspoons

60% of 9 teaspoons is 5.4 teaspoons. We used 5 teaspoons because we were just shy of 3 pounds.

Links:

 

http://en.wikipedia.org/wiki/Sauerkraut
http://www.germanfoodguide.com/sauerkraut.cfm
http://wiki.answers.com/Q/How_much_vitamin_C_is_in_an_orange
http://cashsunshine.blogspot.com/2008/09/cabbage-rich-source-of-vitamins-and.html

2 comments:

  1. Types of molecular targeted therapy

    The reason why the molecular targeted therapy be closely watched, and cause researchers' interest, because it change the characteristics of the tumor cells as a target at the same time play a stronger anti-tumor activity, less toxic to normal cells side effects. This targeted treatment for cancer treatment indicate a new direction.
    According to the target and the nature of the role of drugs, the major molecular targeted therapy drugs are divided into the following categories:
    1 small molecule epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors, such as gefitinib imatinib (Gefitinib, Iressa, Iressa); erlotinib (Erlotinib, Tarceva);
    (2) anti-EGFR monoclonal antibody, cetuximab (Cetuximab, Erbitux);
    Anti-HER-2 monoclonal antibody, such as Herceptin (Trastuzumab Herceptin);
    4.Bcr-ABL tyrosine kinase inhibitors such as imatinib (Imatinib);
    Vascular endothelial growth factor receptor inhibitors, such as Bevacizumab (Avastin Avastin), Endostar;
    6 anti-CD20 monoclonal antibody, rituximab (Rituximab);
    7.IGFR-1 kinase inhibitors, such as NVP-AEW541;
    8.mTOR kinase inhibitors, such as CCI-779;
    Ubiquitin - proteasome inhibitor, bortezomib (bortezomib, Velcade);
    10, such as Aurora kinase inhibitors, histone deacetylases (HDACs) inhibitors.

    Medchemexpress Can provide the above product,its website:www.medchemexpress.com



    Tandutinib
    KW-2449
    Quizartinib
    AST 487
    Linifanib
    Canertinib
    Canertinib dihydrochloride
    CP-724714 (E-Double bond)
    2-Methoxyestradiol
    GSK1904529A

    ReplyDelete
  2. Pfizer apply to the EU marketing authorization of the anti-cancer drug Axitinib

    It is reported that Pfizer said it has submitted a marketing authorization application of drug candidates for the treatment of advanced renal cell carcinoma axitinib. Renal cell carcinoma is the most common form of kidney cancer.

    The company is based on the findings is seeking Food and Drug Administration approval. The results of these studies show that, compared with patients given Nexavar treatment given axitinib treatment patients can survive longer without disease progression. Nexavar is an anti-cancer drug was approved in December 2005.

    June 1, Pfizer requests the EU regulatory approval of axitinib as other treatments ineffective treatment of advanced renal cell carcinoma patients.

    The New York drugmaker said, there are around 21 people are diagnosed with kidney cancer, there are about 102,000 patients die from the disease. It said that about 20% of patients can survive for five years or more.

    Nexavar by Onyx Pharmaceuticals and Bayer HealthCare sales. The drug is also approved for the treatment of liver cancer



    Medchemexpress Can provide the above product,its website:www.medchemexpress.com



    GSK1904529A
    Linsitinib
    NVP-ADW742
    BMS-536924
    GSK1904529A
    NVP-AEW541
    Linsitinib
    Pazopanib
    Crenolanib
    Toceranib

    ReplyDelete